Compare Cassava Sciences Inc (FLNA) vs Iron Mountain Inc (IRM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Iron Mountain Inc — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Iron Mountain Inc trades at $122.95 (market cap $36.75B). The key difference: Iron Mountain Inc is far larger — about 691.6× Cassava Sciences Inc's market cap, and Iron Mountain Inc pays a 2.8% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | IRM | |
|---|---|---|
Market Cap | $53.14M | $36.75B |
Sector | Health | Real Estate |
52-Week High | $4.64 | $133.06 |
52-Week Low | $1.09 | $78.86 |
Enterprise Value | -$33.43M | $55.88B |
Dividend Yield | — | 2.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Iron Mountain (IRM) trades at $122.66, up 0.24% on the day, with a bullish analyst consensus price target of $138.67. Recent earnings beats and strong data center growth drive optimism, but high debt levels and a negative shareholder equity position pose fundamental risks. The technical picture is mixed, with moving averages bullish but oscillators bearish, and the stock is trading near key resistance at $123.
The outlook is cautiously optimistic, supported by recurring revenue streams and data center expansion, yet elevated valuation multiples and significant leverage require careful monitoring. Investment opportunity lies in execution on growth initiatives, while primary risks include interest rate sensitivity and competitive pressures in the information management sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →
